Canaccord Genuity Maintains a 'Hold' on Medifast (MED); Opportunity in Mexico
Tweet Send to a FriendGet Alerts MED Hot Sheet
Price: $28.05 +2.15%
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade MED Now!
Canaccord Genuity maintains a 'Hold' on Medifast (NYSE: MED) price target of $19.00.
Analyst, Scott Van Winkle, said, "We maintain our rating as we look for visibility on health coach trends in the Take Shape for Life channel and for earnings pressure from the clinic expansion to subside...Announces partnership with Productos Medix establishing Medix as the exclusive distributor of Medifast products and programs in Mexico...The deal is low risk, requires no capital and is entirely incremental. We view the deal favorably."
However, Van Winkle doesn't think the deal will positive affect earnings outlook until at least 2012...maintains current estimates.
For an analyst ratings summary and ratings history on Medifast click here. For more ratings news on Medifast click here.
Shares of Medifast closed at $18.86 yesterday, with a 52 week range of $12.97-$24.81.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Scott Van Winkle, said, "We maintain our rating as we look for visibility on health coach trends in the Take Shape for Life channel and for earnings pressure from the clinic expansion to subside...Announces partnership with Productos Medix establishing Medix as the exclusive distributor of Medifast products and programs in Mexico...The deal is low risk, requires no capital and is entirely incremental. We view the deal favorably."
However, Van Winkle doesn't think the deal will positive affect earnings outlook until at least 2012...maintains current estimates.
For an analyst ratings summary and ratings history on Medifast click here. For more ratings news on Medifast click here.
Shares of Medifast closed at $18.86 yesterday, with a 52 week range of $12.97-$24.81.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
- UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
